Reported Apr 22, 2015 · Terminated

Cartia XT (diltiazem HCl extended-release capsules, USP), Once-A-Day Dosage, 300 mg, 90-count bottles, Rx only,…

Actavis Laboratories, FL, Inc.

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Actavis Laboratories, FL, Inc. · 4955 Orange Dr · Davie, FL · 33314-3902

Is this the product you have?

  • Cartia XT (diltiazem HCl extended-release capsules, USP), Once-A-Day Dosage, 300 mg, 90-count bottles, Rx only
  • Manufactured byWatson Laboratories, Inc., Corona, CA --- NDC 62037-0600-90
Lot codes and dates
    • Lot # 956000M
    • Exp. Aug 2016
    • UPC 3-6203760090-6
Amount recalled
2,628 bottles

Where it was sold

  • Nationwide

Why it was recalled

Presence of Foreign Substance; fine residue or dust identified as aluminum may be on exterior of the capsule shell

This product is unlikely to cause harm, but it breaks a safety or labelling rule.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Actavis Laboratories, FL, Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Dec 30, 2016 · Data as of Sep 19, 7:11 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.